HR Stock Price Prediction
Healthcare Realty Trust Incorporated
Based on 24/7 Wall St.'s proprietary analysis, we are setting a target price of $20.81 for Healthcare Realty Trust Incorporated (HR) over the next 12 months. This target price suggests a 8.11% upside from the current price of $19.25. In an optimistic scenario, HR could reach as high as $23.26, while our conservative scenario places the floor at $18.22. Wall Street analyst sentiment shows 3 Buy, 8 Hold, and 0 Sell ratings from 11 analysts covering the stock.
Current Price
$19.25
Target Price
$20.81
Optimistic Scenario
$23.26
Conservative Scenario
$18.22
The Bottom Line
Healthcare Realty Trust Incorporated appears attractively valued at current levels. With a 8.1% upside to our $20.81 target, the risk-reward profile looks favorable for investors with a 12-month time horizon. Wall Street agrees, with 27% of analysts rating it a Buy.
12-Month Price Scenarios
Where HR could be in one year
This chart shows three potential price paths for HR over the next 12 months: our Target Price, an Optimistic Scenario, and a Conservative Scenario. Learn how we calculate our price targets →
Loading chart...
Catalysts
Factors that could drive upside
In our optimistic scenario, HR could reach $23.26 (+20.8% from current price). Key catalysts include:
- Better-than-expected earnings results
- Favorable sector and market conditions
- Positive analyst revisions or upgrades
Risks
Factors that could limit upside
In our conservative scenario, HR could fall to $18.22 (-5.4% from current price). Key risks include:
- Earnings misses or guidance cuts
- Broader market or economic headwinds
- Increased competition or margin pressure
Analyst Sentiment
11 analysts covering HR
The 24/7 Factor
Our proprietary price adjustment model
24/7 Wall St.'s stock forecasts utilize a number of factor adjustments that either increase or decrease a stock's 12-month price target. Toggle the factors our model uses on or off below to see how each impacts HR's share price.
Our Adjustment
1.085×
Adjusted Target
$20.81
Factor Components Toggle to simulate
5-Year Price Projection
Long-term quarterly forecast through 2031
Optimistic Scenario
$31.46
+63.4%
Target Price
$26.28
+36.5%
Conservative Scenario
$19.91
+3.4%
Long-term projections factor in increased uncertainty over time.
Frequently Asked Questions
HR stock price predictions and forecasts
What is the HR stock price prediction for 2030?
Looking ahead to 2030, our model projects HR could trade at an average price of $24.69, with a potential range between $18.52 and $30.87. This represents a potential 28.3% return from today's price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.
Is HR a buy, sell, or hold right now?
24/7 Wall St. currently rates HR as a BUY. Moderate upside (+8.1%) Among Wall Street analysts, 3 rate it Buy, 8 rate it Hold, and 0 rate it Sell.
What is the HR stock price target in an optimistic scenario?
In our optimistic scenario for HR, the stock could reach $23.26 over the next 12 months, representing a 20.8% gain from today's price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.
What is the downside risk for HR stock?
Our conservative scenario projects HR at $18.22 over the next 12 months, a modest 5.4% decline from today. This suggests relatively limited downside risk, though investors should still consider potential headwinds like earnings misses or market weakness.
How accurate are HR stock price predictions?
Stock price predictions are forward-looking estimates, not guarantees. Our model for HR incorporates analyst consensus, valuation metrics, technical indicators, and market sentiment. However, actual stock performance depends on many unpredictable factors including earnings surprises, macroeconomic changes, and market psychology. We provide optimistic and conservative scenarios alongside our target price to illustrate the range of potential outcomes. Always conduct your own research before investing.